Singlera Genomics Incorporated Employee Directory
Biotechnology ResearchCalifornia, United States11-50 Employees
Singlera Genomics is a biotechnology research company based in La Jolla, California, developing liquid biopsy reagents and software to analyze DNA methylation patterns in cell-free DNA. It focuses on identifying methylation haplotypes across thousands of genomic locations and offers assays such as PanSeer for early cancer detection and ColonES for colorectal cancer screening, with PanSeer aiming to detect cancer years before conventional diagnosis through targeted methylation analysis and ColonES delivering high sensitivity for early disease and high specificity for healthy individuals. Singlera is currently pre-commercial and seeks collaboration to bring its technology to market. In May 2023, the FDA granted Breakthrough Device Designation for its PDACatch assay, a methylation-based liquid biopsy for detecting pancreatic cancer in individuals at high risk.